2-(2-((4-methylbenzyl)oxy)phenyl)oxazolo[5,4-b]pyridine

ID: ALA4098123

PubChem CID: 137662265

Max Phase: Preclinical

Molecular Formula: C20H16N2O2

Molecular Weight: 316.36

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(COc2ccccc2-c2nc3cccnc3o2)cc1

Standard InChI:  InChI=1S/C20H16N2O2/c1-14-8-10-15(11-9-14)13-23-18-7-3-2-5-16(18)19-22-17-6-4-12-21-20(17)24-19/h2-12H,13H2,1H3

Standard InChI Key:  MLKMCXXAERARMU-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 24 27  0  0  0  0  0  0  0  0999 V2000
   13.9659   -9.1123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3745   -9.8214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1917   -9.8214    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6003   -9.1123    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.1917   -8.4033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3745   -8.4033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1634   -9.2831    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   13.0793  -10.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.8266  -10.4279    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.3703  -10.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6653  -10.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9562  -10.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9562  -11.3234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6653  -11.7320    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3703  -11.3234    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6653   -9.2804    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.9562   -8.8719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2512   -9.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5422   -8.8719    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8331   -9.2804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.8331  -10.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.5422  -10.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.2512  -10.0976    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1240  -10.5062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  2  0
  3  4  1  0
  4  5  2  0
  5  6  1  0
  1  6  2  0
  7  8  1  0
  8  9  2  0
  1  7  1  0
  2  9  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 10 15  2  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 18 23  2  0
 21 24  1  0
 16 17  1  0
 11 16  1  0
  8 10  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4098123

    ---

Associated Targets(Human)

SGMS2 Tchem Phosphatidylcholine:ceramide cholinephosphotransferase 2 (194 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SGMS1 Tchem Phosphatidylcholine:ceramide cholinephosphotransferase 1 (149 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 316.36Molecular Weight (Monoisotopic): 316.1212AlogP: 4.78#Rotatable Bonds: 4
Polar Surface Area: 48.15Molecular Species: NEUTRALHBA: 4HBD:
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 4.57CX LogD: 4.57
Aromatic Rings: 4Heavy Atoms: 24QED Weighted: 0.54Np Likeness Score: -1.04

References

1. Qi XY, Cao Y, Li YL, Mo MG, Zhou L, Ye DY..  (2017)  Discovery of the selective sphingomyelin synthase 2 inhibitors with the novel structure of oxazolopyridine.,  27  (15): [PMID:28619536] [10.1016/j.bmcl.2017.05.074]

Source